Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use THYQUIDITY ® safely and effectively. See full prescribing information for THYQUIDITY ® . THYQUIDITY ® (levothyroxine sodium) oral solution Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
Hypothyroidism THYQUIDITY is indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression THYQUIDITY is indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use: THYQUIDITY is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with THYQUIDITY may induce hyperthyroidism [see Warnings and Precautions (5.4) ]. THYQUIDITY is not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
- generic_name
- levothyroxine sodium
- product_names
- Levothyroxine Sodium
- ndc
- 52652-1950, 52652-1950-2, 52652-1950-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en